M
10b5-1 Plan
$ Value
$31K
Shares
10,000
Price
$3
Filed
Dec 10
Insider
Name
Hasnain Faheem
Title
—
CIK
0001352620
Roles
Director
Transaction Details
Transaction Date
2025-12-09
Code
M
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
33,983
Footnotes
The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 8, 2025. | This transaction was executed in multiple trades at prices ranging from $10.60 to $11.53. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Filing Info
Hasnain Faheem's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-01-02 | GOSS | A | $0 |
| 2026-01-02 | GOSS | A | $0 |
| 2025-12-09 | KURA | M | $31K |
| 2025-12-09 | KURA | ▼ | $110K |
| 2025-10-01 | GOSS | A | $0 |
| 2025-06-05 | KURA | A | $0 |
Other Insiders at KURA (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
WILSON TROY EDWARD
President and CEO
|
— | — | 2026-03-23 |
|
FORD KATHLEEN
Chief Operating Officer
|
— | $15K | 2026-01-27 |
|
Bair Teresa Brophy
Chief Legal Officer
|
— | $95K | 2026-01-27 |
|
DOYLE THOMAS JAMES
SVP, Finance & Accounting
|
— | $60K | 2026-01-27 |
|
Powl Brian T.
Chief Commercial Officer
|
— | $54K | 2026-01-27 |
|
Leoni Mollie
Chief Medical Officer
|
— | $69K | 2026-01-27 |
|
Burrows Francis
Chief Scientific Officer
|
— | $11K | 2026-01-27 |